Oscar Health (NYSE:OSCR) Upgraded by Wall Street Zen to “Hold” Rating

Oscar Health (NYSE:OSCR) was upgraded by equities research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report released on Saturday.

Several other research firms have also commented on OSCR. Piper Sandler decreased their price objective on shares of Oscar Health from $14.00 to $13.00 and set a “neutral” rating for the company in a research note on Thursday, August 14th. Robert W. Baird reaffirmed a “neutral” rating and set a $14.00 price target (down from $28.00) on shares of Oscar Health in a research report on Friday, July 25th. The Goldman Sachs Group started coverage on Oscar Health in a report on Tuesday, October 14th. They set a “neutral” rating and a $17.00 price target on the stock. Wells Fargo & Company reduced their price objective on Oscar Health from $14.00 to $11.00 and set an “underweight” rating for the company in a research note on Thursday, November 13th. Finally, Baird R W cut Oscar Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 25th. Six research analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Reduce” and an average price target of $13.14.

Oscar Health Price Performance

Shares of NYSE:OSCR opened at $13.46 on Friday. The company has a current ratio of 0.92, a quick ratio of 0.92 and a debt-to-equity ratio of 0.67. The stock has a market cap of $3.56 billion, a PE ratio of -12.02 and a beta of 1.88. The stock’s fifty day simple moving average is $18.26 and its two-hundred day simple moving average is $16.89. Oscar Health has a 1-year low of $11.20 and a 1-year high of $23.80.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, November 6th. The company reported ($0.53) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.55) by $0.02. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. The firm had revenue of $2.93 billion during the quarter, compared to analyst estimates of $3.09 billion. During the same quarter in the prior year, the business posted ($0.22) EPS. The business’s revenue was up 23.2% compared to the same quarter last year. Oscar Health has set its FY 2025 guidance at EPS. As a group, analysts forecast that Oscar Health will post 0.69 EPS for the current fiscal year.

Insider Buying and Selling

In other Oscar Health news, insider Mario Schlosser sold 395,000 shares of the stock in a transaction on Monday, September 22nd. The stock was sold at an average price of $18.43, for a total transaction of $7,279,850.00. Following the completion of the transaction, the insider directly owned 501,148 shares of the company’s stock, valued at approximately $9,236,157.64. This represents a 44.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 24.39% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. CIBC Bancorp USA Inc. bought a new position in shares of Oscar Health during the 3rd quarter worth $392,000. EMC Capital Management lifted its holdings in Oscar Health by 336.7% during the third quarter. EMC Capital Management now owns 13,100 shares of the company’s stock valued at $248,000 after purchasing an additional 10,100 shares during the last quarter. Advisory Services Network LLC boosted its position in Oscar Health by 390.1% during the third quarter. Advisory Services Network LLC now owns 39,235 shares of the company’s stock worth $743,000 after purchasing an additional 31,229 shares during the period. Marathon Asset Management LP increased its stake in shares of Oscar Health by 66.7% in the third quarter. Marathon Asset Management LP now owns 75,000 shares of the company’s stock worth $1,420,000 after purchasing an additional 30,000 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. increased its stake in shares of Oscar Health by 31.0% in the third quarter. Jacobs Levy Equity Management Inc. now owns 303,603 shares of the company’s stock worth $5,747,000 after purchasing an additional 71,932 shares in the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.